中央区局灶性皮质发育不良2型癫痫手术的获益与风险
该回顾性单中心研究纳入2000至2019年经组织学确诊的中央区局灶性皮质发育不良2型(FCD2)连续患者60例,评估癫痫手术后的发作结局与功能风险。术后2至20年随访中53例(88%)无发作,37例(62%)达Engel IA级,与FCD2完全切除相关;早期暂时性术后缺损52例(87%),永久性缺损31例。作者认为中央区FCD2切除可获得良好发作结局和较低的主要永久性残疾率。
要点
- 中央区FCD2切除术后88%患者无发作,62%达Engel IA级,与病灶完全切除相关。
- 早期暂时性术后缺损见于87%患者,永久性缺损31例,其中主要缺损3例。
- 儿童患者无发作且无缺损(48%)或仅轻微缺损(28%)的比例显著更高(p=0.025)。
核心结论
- 中央区FCD2切除术后可获得良好的癫痫发作结局和较低的主要永久性残疾率,尽管存在功能风险。
- 因属回顾性研究,本研究提供IV级证据,表明中央区癫痫手术后可获得良好发作结局并仅附加轻微缺损。
研究设计与样本
- 回顾性研究,纳入2000至2019年间在单中心连续手术、经组织学确诊为中央区FCD2的全部患者。
- 共纳入60例患者(女性35例,年龄7至65岁)。
- 分析内容包括电临床与影像学特征(含fMRI)、发作结局以及术后早期和晚期神经功能状态,并与解剖功能分区(初级运动皮层[PMC]、旁中央小叶[PCL]、辅助运动区[SMA]、中央前回[PrCG]、中央后回[PoCG]、中央盖[COp])进行关联。
主要发现
- 癫痫特征为早发、高发作频率伴丛集性发作(30-90次/日)、跌倒发作和癫痫持续状态;发作期症状学包括感觉运动先兆、运动和姿势表现及发作后运动缺损。
- MRI阳性率为63%,18F-氟脱氧葡萄糖-PET阳性率为86%;fMRI显示激活区邻近FCD2(59%)或轻微重组(41%),无激活区位于病灶内。
- 术后2至20年随访中53例(88%)无发作,其中37例(62%)达Engel IA级,与FCD2完全切除相关。
- 早期暂时性术后缺损见于52例(87%),其中19例为严重缺损,多发生于PMC、PCL和SMA切除后,而PrCG、PoCG和COp切除与轻微/中度缺损相关;52例中21例(40%)完全恢复,31例(轻微19例、中度9例、重度3例)永久性缺损持续超过2年。
- 无发作且无缺损(48%)或无发作且仅轻微缺损(28%)的最佳结局在儿童中显著更常见(p=0.025);28例(47%)停用抗癫痫发作药物;43例(72%)报告学业或社会职业状况改善;生活质量与无发作结局及无术后缺损相关。
局限性
- 本研究为回顾性研究,提供IV级证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Focal cortical dysplasia type 2 (FCD2) in the central region can cause drug-resistant epilepsy for which surgery remains challenging because of subsequent functional deficits. Advances in imaging and surgical techniques have progressively improved outcome. We aimed to assess the benefits on epilepsy and the functional risks after FCD2 resections in these highly eloquent areas. METHODS: We retrospectively studied all consecutive patients with histologically confirmed FCD2 located in the central region operated on between 2000 and 2019 at a single center. We analyzed electroclinical and imaging features (including fMRI), seizure outcome, and early and late postoperative neurologic status correlating to anatomo-functional areas (primary motor cortex [PMC], paracentral lobule [PCL], supplementary motor area [SMA], precentral gyrus [PrCG], postcentral gyrus [PoCG], central operculum [COp]). RESULTS: Sixty patients (35 female, age 7-65 years) were included in the study. Epilepsy was characterized by early onset, high seizure frequency with clusters (30-90/d), drop attacks, and status epilepticus. Ictal semiology included sensory-motor auras, motor and postural manifestations, and postictal motor deficits. EEG and stereo-EEG patterns were like those typically recorded in FCD2. MRI was positive in 63% and 18F-fluorodeoxyglucose-PET was positive in 86% of the patients. fMRI demonstrated activations close to the FCD2 (59%) or minor reorganization (41%) but none within the lesion. Seizure-free outcome (2- to 20-year follow-up) was obtained in 53 patients (88%), including 37 achieving Engel class IA (62%), correlating with complete FCD2 removal. Early transitory postoperative deficits occurred in 52 patients (87%), which were severe in 19, mostly after PMC, PCL, and SMA resections, while PrCG, PoCG, and COp resections were associated with minor/moderate deficits. Total recovery was observed in 21 of 52 patients (40%), while a permanent deficit (>2 years) persisted in 31 (minor 19, moderate 9, major 3). The best outcome (seizure freedom without deficit [48%] or with minor deficit (28%]) was significantly more frequent in children (p = 0.025). Antiseizure medications were discontinued in 28 patients (47%). Quality of life correlated with seizure-free outcome and absence of postoperative deficit; 43 patients (72%) reported a schooling or socio-professional improvement. DISCUSSION: Excellent seizure outcome and low rates of major permanent disability can be achieved after central FCD2 resections despite functional risks. CLASSIFICATION OF EVIDENCE: Due to its retrospective nature, this study provides Class IV evidence that good seizure outcomes with minor additional deficits can be achieved after epilepsy surgery in the central region.
引用
- Chassoux F, Mellerio C, Laurent A, et al. Benefits and Risks of Epilepsy Surgery in Patients With Focal Cortical Dysplasia Type 2 in the Central Region. Neurology. 2022. PMID: 35418453. doi:10.1212/WNL.0000000000200345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。